Yahoo Finance

Global Market for PCR in Point-of-Care Diagnostics Projected to Reach $2.1 Billion by 2029

Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market · GlobeNewswire Inc. Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction (PCR) for Point-of-Care ...

Point-of-Care Testing, Falling Prices and PCR Threaten the Immunoassay Lab Model: What Diagnostics Leaders Must Do Next

Forecasts by application, technology and care setting show where hospital and outpatient lab spending is shifting, with strategies from 64 players including Roche, Abbott and Siemens ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
News Medical

Revolutionising point-of-care molecular diagnostics with a sub 10 minute PCR test

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...
MarketWatch

Breaking the PCR-Only Barrier: Dual 510(k) Clearance and CLIA-Waiver Establish FINDER as the First Molecular Point-of-Care Platform with Multifunctional Capabilities

The MarketWatch News Department was not involved in the creation of this content. DURHAM, N.C., March 31, 2026 /PRNewswire/ -- Baebies announced FDA 510(k) clearance and CLIA-waiver approval for the ...
Morningstar%2c Inc.

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

SALT LAKE CITY, June 2, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...
Medscape

Point-Of-Care Test Enhances STI Care in Emergency Department

Integrating a rapid point-of-care polymerase chain reaction (PCR) testing for sexually transmitted infections (STIs) in the emergency department (ED) reduced the length of stay of patients by 76 ...
Seeking Alpha

Co-Diagnostics, Inc. Initiates Clinical Evaluations for its At-Home and Point-of-Care Co-Dx PCR Home™ Platform

SALT LAKE CITY, Feb. 22, 2023 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
McKnight's Long-Term Care News

Point-of-care PCR tests decreased ED transfers among NH residents, study finds

Your browser does not support the audio element. The use of point-of-care respiratory multiplex polymerase chain reaction (POC-RMPCR) in nursing homes did not affect ...
BIOENGINEER

Faster PCR Results in Ventilator-Associated Pneumonia May Not Speed Up Antibiotic Decisions

A new correspondence in Intensive Care Medicine argues that rapid multiplex PCR results in ventilator-associated pneumonia ...
Hosted on MSN

Co-Diagnostics files FDA 510(k) for flu and RSV PCR test

Co-Diagnostics has filed a Dual 510(k) premarket notification with the US Food and Drug Administration (FDA) for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test, run on the Co-Dx PCR Pro ...